- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03809520
An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa Hospitals and Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals 18 to 70 years old Sustained an intra-articular fracture of the tibial plafond Indicated for operative treatment Present for treatment within 4 weeks of injury
Exclusion Criteria:
- Women who are pregnant or planning on becoming pregnant Individuals younger than 18 and older than 70
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: pedCAT
Subjects will undergo weight-bearing CT (pedCAT) imaging at 6 months, 12 months, and 18 months post-ankle injury. Additional funding was secured and follow-up for subjects initially enrolled under OTA funding was extended to include yearly follow-up through 5 years post ankle injury |
Weight-bearing CT scan (pedCAT) of ankles to measure 3D joint space width following ankle fracture.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the Ankle Joint Space Width Between Baseline and Final Follow-up
Time Frame: Final imaging assessed at 18 months or up to 5 years post-injury
|
Tracking longitudinal changes in the 3D joint space width as seen in pedCAT imaging at the final follow-up visit using contralateral, uninjured side as control. Final follow-up occurred at 18 month follow-up or at 5 years follow-up. |
Final imaging assessed at 18 months or up to 5 years post-injury
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Ankle Pain
Time Frame: final follow-up occurred at either 18 months or up to 5 years post-injury
|
Subjective measure of foot and ankle pain gathered by patient reported outcomes questionnaire at final follow-up visit.
The Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference instrument was utilized.
Scores are reported as T-scores from a representative group of US adults.
The mean for the US population is 50 and the standard deviation is 10.
HIgher PROMIS T-scores indicate a greater amount of the health domain being measured.
In this case, a higher T-score of PROMIS Pain Interference indicates greater pain.
|
final follow-up occurred at either 18 months or up to 5 years post-injury
|
|
Change in Ankle Function
Time Frame: 18 months or up to 5 years post-injury
|
Subjective measure of foot and ankle function measured using the Foot and Ankle Ability Measure (FAAM) questionnaire. Scores range from 0-100%. higher is better. Scores were initially collected at 6 month visit Final scores collected at 18 month visit or up to 5 years post-injury |
18 months or up to 5 years post-injury
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: J L Marsh, MD, University of Iowa
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201612747
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-traumatic Osteoarthritis
-
Zimmer, GmbHTerminatedKnee Osteoarthritis | Post-traumatic OsteoarthritisUnited Kingdom, Germany, Netherlands
-
Keller Army Community HospitalUniversity of North Carolina, Chapel Hill; Uniformed Services University of...Active, not recruitingPost-traumatic Osteoarthritis | Knee Injuries | Knee SprainUnited States
-
J L MarshUnited States Department of DefenseCompletedOsteoarthritis | Post-traumatic OsteoarthritisUnited States
-
James StannardCompletedPost-traumatic OsteoarthritisUnited States
-
Istituto Ortopedico RizzoliCompletedPost-traumatic Osteoarthritis | Hip OsteoarthritisItaly
-
Affinity Health Research InstituteGenesis Orthopedics and Sports Medicine; The Center for Primary Care and Sports...UnknownPost-Traumatic Osteoarthritis of KneeUnited States
-
University Hospital, GhentCompletedOsteoarthritis Thumb | Post-traumatic; ArthrosisBelgium
-
Zimmer BiometActive, not recruitingRheumatoid Arthritis | Knee Osteoarthritis | Post-traumatic OsteoarthritisAustria
-
Sport Injury Prevention Research CentreUnknownOsteoarthritis Knees Both Post-TraumaticCanada
-
Brigham and Women's HospitalArthritis FoundationRecruitingOsteoarthritis, Knee | Post-traumatic Osteoarthritis | ACL TearUnited States